XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.4
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Measurements The following table summarizes our investments that are recognized in our consolidated balance sheets at December 31 using fair value measurements determined based on the differing levels of inputs. This table excludes investments held by consolidated sponsored investment products which are presented separately on our consolidated balance sheets and are detailed in Note 7.
20222021
(in millions)Level 1Level 2Level 3Level 1Level 2Level 3
T. Rowe Price investment products
Cash equivalents held in money market funds$1,412.0 $— $— $1,183.9 $— $— 
Discretionary investments242.0 — — 518.7   
Seed capital161.0 34.1 — 241.4 23.4 — 
Supplemental savings plan liability economic hedges760.7 — — 881.5 — — 
Other investments.6 .1 — .7 .1 — 
Investments in affiliated collateralized loan obligations— 6.4 — — 10.8 — 
Total$2,576.3 $40.6 $— $2,826.2 $34.3 $— 
Contingent consideration liability$— $— $95.8 $— $— $306.3 
Schedule of Change in Contingent Consideration Liability
The change in the contingent consideration liability measured at fair value for which we used Level 3 inputs to determine fair value is as follows:

Contingent Consideration Liability
(in millions)Year ended 12/31/2022
Balance at beginning of period$306.3 
  Measurement period adjustment(49.3)
  Unrealized gains, included in earnings(161.2)
Balance, December 31, 2022
$95.8